Rohit Loomba
@DrLoomba
Followers
6K
Following
16K
Media
343
Statuses
4K
Liver doctor/Professor of Medicine/clinical trial design Phase 1-4/inventor/drug developer/life's goal to find a cure for liver fibrosis & NASH.
San Diego, California
Joined December 2011
Go team @UCSD_GI ! Terrific achievement and a brilliant team effort!!! @MASLDResearch @Bernd_Schnabl @AjmeraVeeral @UCPrezDrake @CALonghurst @EASLnews @INASL_Liver @GraceSu15 @SDDRC
8
4
78
Great pleasure co-authoring this review with my good friend @phil_newsome7 .JCI - Therapeutic horizons in metabolic dysfunction–associated steatohepatitis .@AASLDtweets @the_asci @EASLnews @CALonghurst @APASLnews @INASL_Liver.
0
11
38
Nice editorial by @ggarciatsao !.
Original Article: Efruxifermin in Compensated Liver Cirrhosis Caused by MASH (SYMMETRY trial) . Editorial: Redefining End Points in MASH Cirrhosis . #Gastroenterology
1
2
12
RT @LancetGastroHep: Efimosfermin alfa – a long-acting FGF21 analogue – for metabolic dysfunction-associated steatohepatitis. https://t.co/….
0
11
0
A stepwise, noninvasive strategy with FIB-4 followed by VCTE accurately identifies fibrosis risk in people with suspected #MetALD, helping to catch more cases and reduce missed diagnoses.
2
8
21
Way to go @DrHuangDQ !!.
Dr. Daniel Huang (@DrHuangDQ) joins #WCOG_AGW25!. A transplant hepatologist, he brings immense expertise in #HCC, #MASLD and hepatitis B with 200+ papers & AGA guideline contributions. Catch him in Melbourne this September!.🔗
0
1
14
Thanks @BritSocGastro for a very special session with @WenhaoLi29 Amy Johnson who talked about their experience @MASLDResearch @UCSDalumni as BSG Liver Fellow! Thanks @QAnstee @CoralHollywood for an amazing Liver faculty dinner
0
5
30
Pancreas Clinical Section Talks covering a wide range of topics. Thank you to our international speakers from China, India and Spain @BritSocGastro @Samanta_JayPGI
1
1
6
Great evening @BritSocGastro at the Royal College of Physicians and Surgeons Glasgow Scotland - met some amazing GI & hepatologists from around the 🌎 !! @AASLDtweets @CoralHollywood @PhilSmithIsBack @DebbieShawcros1
0
6
48
Thank you so much @BritSocGastro and @CoralHollywood @QAnstee @PhilSmithIsBack for the kind invitation- great vibe at the Royal College of Physicians and Surgeons in Glasgow !!! @AASLDtweets @MASLDResearch @AmerGastroAssn
0
4
23
Great line up of speakers!!!.
📢 Upcoming #EASLDeepDive on 25 June, 18:00 CEST. How should we diagnose and stratify risk in #MASLD?.Join experts as they explore the 2024 EASL–EASD–EASO Guidelines:.👉New MASLD definition & SLD framework.👉Non-invasive tests: when, how, for whom.👉#HCC risk & surveillance
0
1
4
Keep it up @LuisAntonioDiaz ! This is a key piece that other liver centers can use to change their protocol to give injectable once a month naltrexone to their advanced ALD patients before discharge from the hospital.
New data w/@DrLoomba @MASLDResearch on extended-release naltrexone (XR-NTX) in advanced ALD:. In this case series, XR-NTX was well tolerated in patients with compensated ALD (64% cirrhosis)— no hepatotoxicity, no severe adverse events. 👉 #LiverTwitter
0
6
21
New data @LuisAntonioDiaz @MASLDResearch on use of once monthly injectable naltrexone in patients with advanced ALD -Safety and Tolerability of Injectable Extended-Release Naltrexone for the Management of AUD in Adv… .@AASLDtweets.
1
8
21
Keep it up @f_tavaglione ! Way to go! Thanks @JHepatology !.
🚨Finally out in @JHepatology 🚨. Our new paper explores the clinical utility of PEth🍷 to detect underreported alcohol use and enhance SLD subclassification. A huge thanks🙏 to my mentor @DrLoomba for the opportunity to lead this project!. 📖 Read more:
0
2
15
Excellent data on Mazdutide on weight loss - look forward to data on changes in Liver fat by MRI-PDFF in future!.
Original Article: Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight (GLORY-1 trial) . Editorial: Overweight and Obesity — Capturing the Whole Picture . #Endocrinology #Gastroenterology
0
6
13
Thanks @UCPrezDrake for recognizing our @UCSD_GI team @UCSDHealth — gratitude 🙏 @pattymaysent @CALonghurst @saulkarpen @AmerGastroAssn @AmCollegeGastro @AASLDtweets.
0
0
13
Great meeting @GuildConference - highly recommended GI and liver CME @UmaMahadevanIBD @norahterrault !.
Not to soon to plan your winter symposia. Here is a clip of @DrLoomba discussing MASLD from 2025 @GuildConference
0
3
11
RT @GutGirlMD: #LeadershipYou conference listening to amazing leaders. @AmCollegeGastro . Dr John Carethers, MD, FACG highlighting honesty….
0
9
0
Our new paper on Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with MASH: a randomised, phase 2a trial - The Lancet Gastroenterology & Hepatology .@mromerogomez @DrHuangDQ @AlkhouriNaim @NoureddinMD @QAnstee @CALonghurst
1
20
54
RT @AASLDtweets: At #EASL2025, AASLD President Dr. Grace Su chaired 2 sessions, EASL/AASLD Endpoints Conference on #MetALD & ALD, and Gener….
0
6
0